Dose daily India Tightens Oversight as Drugs Controller General of India Targets GLP-1 Misuse By: Dose Daily News Bureau Date: April 14, 2026 Share post: FacebookXPinterestWhatsApp TagsGlp drugGovernment of IndiaPatient safety Previous articleViksit Bharat Shiksha Bill Sparks Debate: What It Means for India’s Scientific and Pharma EcosystemNext articleIndia Moves Toward Affordable Semaglutide with Dr. Reddy’s Laboratories Approval Dose Daily News Bureauhttps://dosedailynews.com/ LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. I want inI've read and accept the Privacy Policy. Dabur India Plant Under US FDA Scanner Over Contamination Concerns Dose Daily News Bureau - June 3, 2026 FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI Breaking News Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines Breaking News FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs Breaking News Top 15 Pharmacy Colleges in West Bengal: Complete Guide for Pharmacy Aspirants (2026) Career & Exams Kwality Wall’s to Serve Only Milk-Based Ice Cream in India by 2027 Breaking News Related articles Breaking News Dabur India Plant Under US FDA Scanner Over Contamination Concerns The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility... Breaking News FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI Wockhardt Limited announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic... Breaking News Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the... Breaking News FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...